MyLam
Lam Research Corporation Reports Financial Results for the Quarter Ended March 26, 2023
April 19, 2023

FREMONT, Calif., April 19, 2023 /PRNewswire/ -- Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended March 26, 2023 (the "March 2023 quarter").

Highlights for the March 2023 quarter were as follows:

  • Revenue of $3.87 billion.
  • U.S. GAAP gross margin of 41.5%, U.S. GAAP operating income as a percentage of revenue of 24.4%, and U.S. GAAP diluted EPS of $6.01.
  • Non-GAAP gross margin of 44.0%, non-GAAP operating income as a percentage of revenue of 28.3%, and non-GAAP diluted EPS of $6.99.

 

Key Financial Data for the Quarters Ended

March 26, 2023 and December 25, 2022

(in thousands, except per-share data, percentages, and basis points) 

 

 

U.S. GAAP

   

March 2023

 

December 2022

 

Change Q/Q

Revenue

 

$                3,869,569

 

$                5,277,569

 

- 26.7 %

Gross margin as percentage of revenue

 

41.5 %

 

45.0 %

 

- 350 bps

Operating income as percentage of revenue

 

24.4 %

 

31.8 %

 

- 740 bps

Diluted EPS

 

$                          6.01

 

$                        10.77

 

- 44.2 %

             

Non-GAAP

   

March 2023

 

December 2022

 

Change Q/Q

Revenue

 

$                3,869,569

 

$                5,277,569

 

- 26.7 %

Gross margin as percentage of revenue

 

44.0 %

 

45.1 %

 

- 110 bps

Operating income as percentage of revenue

 

28.3 %

 

32.1 %

 

- 380 bps

Diluted EPS

 

$                          6.99

 

$                        10.71

 

- 34.7 %

 

U.S. GAAP Financial Results

For the March 2023 quarter, revenue was $3,870 million, gross margin was $1,606 million, or 41.5% of revenue, operating expenses were $663 million, operating income was 24.4% of revenue, and net income was $814 million, or $6.01 per diluted share on a U.S. GAAP basis. This compares to revenue of $5,278 million, gross margin of $2,376 million, or 45.0% of revenue, operating expenses of $696 million, operating income of 31.8% of revenue, and net income of $1,469 million, or $10.77 per diluted share, for the quarter ended December 25, 2022 (the "December 2022 quarter").

Non-GAAP Financial Results

For the March 2023 quarter, non-GAAP gross margin was $1,704 million, or 44.0% of revenue, non-GAAP operating expenses were $608 million, non-GAAP operating income was 28.3% of revenue, and non-GAAP net income was $946 million, or $6.99 per diluted share. This compares to non-GAAP gross margin of $2,382 million, or 45.1% of revenue, non-GAAP operating expenses of $686 million, non-GAAP operating income of 32.1% of revenue, and non-GAAP net income of $1,461 million, or $10.71 per diluted share, for the December 2022 quarter.

"Lam delivered solid March quarter performance, including record foundry-related revenues," said Tim Archer, Lam Research's President and Chief Executive Officer. "With lower wafer fabrication equipment spending in 2023, we are focused on managing costs while making strategic investments for critical manufacturing inflections. Our differentiated solutions and strong installed base business place Lam in an excellent position to outperform when WFE growth resumes."

Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments, and restricted cash and investments balances increased to $5.6 billion at the end of the March 2023 quarter compared to $4.8 billion at the end of the December 2022 quarter. This increase was primarily the result of $1,726 million of cash generated from operating activities, partially offset by $582 million of share repurchases, including net share settlement of employee stock-based compensation; $234 million of dividends paid to stockholders; and $119 million of capital expenditures.

Deferred revenue at the end of the March 2023 quarter increased to $2,003 million compared to $1,984 million as of the end of the December 2022 quarter. Lam's deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $212 million as of March 26, 2023 and $379 million as of December 25, 2022.

Revenue

The geographic distribution of revenue during the March 2023 quarter is shown in the following table:

Region

Revenue

Korea

22 %

China

22 %

Taiwan

18 %

United States

16 %

Japan

10 %

Europe

8 %

Southeast Asia

4 %

The following table presents revenue disaggregated between system and customer support-related revenue:

 

Three Months Ended

 

March 26,
2023

 

December 25,
2022

 

March 27,
2022

 

(In thousands)

System revenue

$              2,256,033

 

$              3,547,518

 

$              2,650,842

Customer support-related revenue and other

1,613,536

 

1,730,051

 

1,409,574

 

$              3,869,569

 

$              5,277,569

 

$              4,060,416

           

 

System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.

Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.

Outlook

For the quarter ended June 25, 2023, Lam is providing the following guidance: 

 

U.S. GAAP

 

Reconciling
Items

 

Non-GAAP

                     

Revenue

$3.1 Billion

+/-

$300 Million

 

 

$3.1 Billion

+/-

$300 Million

Gross margin as a percentage of revenue

43.2 %

+/-

1 %

 

$    26

Million

 

44.0 %

+/-

1 %

Operating income as a percentage of revenue

24.3 %

+/-

1 %

 

$    36

Million

 

25.5 %

+/-

1 %

Net income per diluted share

$4.75

+/-

$0.75

 

$    33

Million

 

$5.00

+/-

$0.75

Diluted share count

134 million

 

 

134 million

 

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or recognized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

  • Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3 million; restructuring charges, $20 million; product rationalization charges, $2 million; and transformational costs, $1 million, totaling $26 million.
  • Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $4 million; restructuring charges, $21 million; transformational costs, $9 million; and product rationalization charges, $2 million; totaling $36 million.
  • Net income per diluted share - amortization related to intangible assets acquired though business combinations, $4 million; amortization of note discounts, restructuring charges, $21 million; transformational costs, $9 million; product rationalization charges, $2 million; amortization of debt discounts, $1 million; and associated tax benefit for non-GAAP items ($4 million); totaling $33 million.

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company's non-GAAP results for both the March 2023 and December 2022 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax effect of non-GAAP items. Additionally, the non-GAAP results for the March 2023 quarter exclude net restructuring charges, product rationalization charges, and transformational costs; and Non-GAAP results for the December 2022 quarter excluded a net income tax benefit associated with legal entity restructuring.

Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company's website at https://investor.lamresearch.com

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; our expectations for wafer fabrication equipment spending and growth; our management of costs;  our investments; the differentiation of our solutions; the strength of our installed base business;  and our performance relative to our industry. Some factors that may affect these forward-looking statements include: trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; supply chain cost increases and other inflationary pressures have impacted and are expected to continue to impact our profitability; supply chain disruptions have limited and are expected to continue to limit our ability to meet demand for our products; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 26, 2022 and our quarterly report on Form 10-Q for the fiscal quarter ended December 25, 2022. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)

Consolidated Financial Tables Follow.

 

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data and percentages)

(unaudited) 

 
 

Three Months Ended

 

Nine Months Ended

 

March 26,
2023

 

December 25,
2022

 

March 27,
2022

 

March 26,
2023

 

March 27,
2022

Revenue

$  3,869,569

 

$  5,277,569

 

$  4,060,416

 

$ 14,221,259

 

$  12,591,485

Cost of goods sold

2,197,237

 

2,901,220

 

2,243,791

 

7,835,743

 

6,820,190

Restructuring charges, net - cost of goods sold

66,720

 

 

 

66,720

 

Total cost of goods sold

2,263,957

 

2,901,220

 

2,243,791

 

7,902,463

 

6,820,190

Gross margin

1,605,612

 

2,376,349

 

1,816,625

 

6,318,796

 

5,771,295

Gross margin as a percent of revenue

41.5 %

 

45.0 %

 

44.7 %

 

44.4 %

 

45.8 %

Research and development

429,451

 

462,385

 

407,120

 

1,325,211

 

1,193,091

Selling, general and administrative

193,500

 

233,802

 

217,408

 

632,922

 

675,735

Restructuring charges, net - operating expenses

40,408

 

 

 

40,408

 

Total operating expenses

663,359

 

696,187

 

624,528

 

1,998,541

 

1,868,826

Operating income

942,253

 

1,680,162

 

1,192,097

 

4,320,255

 

3,902,469

Operating income as a percent of revenue

24.4 %

 

31.8 %

 

29.4 %

 

30.4 %

 

31.0 %

Other income (expense), net

(3,331)

 

(28,234)

 

(57,402)

 

(74,660)

 

(68,260)

Income before income taxes

938,922

 

1,651,928

 

1,134,695

 

4,245,595

 

3,834,209

Income tax expense

(124,914)

 

(183,421)

 

(112,917)

 

(537,201)

 

(437,857)

Net income

$     814,008

 

$  1,468,507

 

$  1,021,778

 

$   3,708,394

 

$  3,396,352

Net income per share:

                 

Basic

$            6.03

 

$         10.80

 

$            7.34

 

$          27.28

 

$          24.17

Diluted

$            6.01

 

$         10.77

 

$            7.30

 

$          27.20

 

$          24.02

Number of shares used in per share calculations:

                 

Basic

134,924

 

136,018

 

139,229

 

135,945

 

140,534

Diluted

135,395

 

136,339

 

140,057

 

136,314

 

141,400

Cash dividend declared per common share

$         1.725

 

$         1.725

 

$            1.50

 

$          5.175

 

$            4.50

                   

 

 LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 
 

March 26,
2023

 

December 25,
2022

 

June 26,
2022

 

(unaudited)

 

(unaudited)

 

(1)

ASSETS

         

Cash and cash equivalents

$              5,305,648

 

$              4,484,716

 

$              3,522,001

Investments

63,849

 

103,130

 

135,731

Accounts receivable, net

3,262,140

 

4,070,088

 

4,313,818

Inventories

4,881,935

 

4,819,966

 

3,966,294

Prepaid expenses and other current assets

216,455

 

230,888

 

347,391

Total current assets

13,730,027

 

13,708,788

 

12,285,235

Property and equipment, net

1,855,117

 

1,863,155

 

1,647,587

Restricted cash and investments

250,688

 

251,344

 

251,534

Goodwill and intangible assets

1,801,819

 

1,805,218

 

1,616,963

Other assets

1,605,710

 

1,577,876

 

1,394,313

Total assets

$            19,243,361

 

$            19,206,381

 

$            17,195,632

LIABILITIES AND STOCKHOLDERS' EQUITY

         

Current portion of long-term debt and finance lease obligations

$                      8,457

 

$                      7,226

 

$                      7,381

Other current liabilities

4,432,872

 

4,539,696

 

4,557,378

Total current liabilities

4,441,329

 

4,546,922

 

4,564,759

Long-term debt and finance lease obligations

4,996,920

 

4,996,057

 

4,998,449

Income taxes payable

885,348

 

862,405

 

931,117

Other long-term liabilities

512,376

 

496,362

 

422,941

Total liabilities

10,835,973

 

10,901,746

 

10,917,266

Stockholders' equity (2)

8,407,388

 

8,304,635

 

6,278,366

Total liabilities and stockholders' equity

$            19,243,361

 

$            19,206,381

 

$            17,195,632

 

 

(1)

Derived from audited financial statements.

(2)

Common shares issued and outstanding were 134,692 as of March 26, 2023, 135,403 as of December 25, 2022, and 136,975 as of June 26, 2022.

 

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, unaudited)

 
 

Three Months Ended

 

Nine Months Ended

 

March 26,
2023

 

December 25,
2022

 

March 27,
2022

 

March 26,
2023

 

March 27,
2022

CASH FLOWS FROM OPERATING ACTIVITIES:

                 

Net income

$           814,008

 

$        1,468,507

 

$        1,021,778

 

$        3,708,394

 

$        3,396,352

Adjustments to reconcile net income to net cash provided by operating activities:

                 

Depreciation and amortization

91,663

 

85,414

 

84,228

 

252,828

 

245,807

Deferred income taxes

7,195

 

(6,680)

 

(56,878)

 

(133,101)

 

(83,451)

Equity-based compensation expense

73,911

 

73,084

 

68,543

 

218,105

 

189,476

Other, net

1,559

 

12,729

 

(3,121)

 

11,537

 

(78,325)

Changes in operating assets and liabilities

738,102

 

(492,867)

 

(356,840)

 

(1,550)

 

(1,014,119)

Net cash provided by operating activities

1,726,438

 

1,140,187

 

757,710

 

4,056,213

 

2,655,740

CASH FLOWS FROM INVESTING ACTIVITIES:

                 

Capital expenditures and intangible assets

(119,457)

 

(163,378)

 

(145,368)

 

(422,898)

 

(420,288)

Business acquisitions, net of cash acquired

 

(119,955)

 

 

(119,955)

 

Net maturities and sales of available-for-sale securities

39,414

 

17,743

 

79,184

 

71,852

 

1,142,398

Other, net

(4,289)

 

(1,657)

 

(28,380)

 

(8,381)

 

(33,898)

Net cash (used for) provided by investing activities

(84,332)

 

(267,247)

 

(94,564)

 

(479,382)

 

688,212

CASH FLOWS FROM FINANCING ACTIVITIES:

                 

Principal payments on debt

(2,209)

 

(17,082)

 

(1,821)

 

(21,145)

 

(9,857)

Treasury stock purchases

(581,943)

 

(456,276)

 

(1,338,006)

 

(1,147,998)

 

(2,989,574)

Dividends paid

(233,977)

 

(235,980)

 

(210,587)

 

(675,572)

 

(607,234)

Reissuance of treasury stock related to employee stock purchase plan

 

44,996

 

 

44,996

 

46,380

Proceeds from issuance of common stock

 

877

 

492

 

7,673

 

4,685

Other, net

(1,399)

 

1,253

 

214

 

(635)

 

197

Net cash used for financing activities

(819,528)

 

(662,212)

 

(1,549,708)

 

(1,792,681)

 

(3,555,403)

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

(2,302)

 

17,878

 

(5,090)

 

(1,349)

 

(13,544)

Net increase (decrease) in cash, cash equivalents, and restricted cash

820,276

 

228,606

 

(891,652)

 

1,782,801

 

(224,995)

Cash, cash equivalents, and restricted cash at beginning of period

4,736,060

 

4,507,454

 

5,337,407

 

3,773,535

 

4,670,750

Cash, cash equivalents, and restricted cash at end of period

$        5,556,336

 

$        4,736,060

 

$        4,445,755

 

$        5,556,336

 

$        4,445,755

                   

 

Non-GAAP Financial Summary

(in thousands, except percentages and per share data)

(unaudited)

 
 

Three Months Ended

 

March 26,
2023

 

December 25,
2022

Revenue

$       3,869,569

 

$       5,277,569

Gross margin

$       1,704,323

 

$       2,381,723

Gross margin as percentage of revenue

44.0 %

 

45.1 %

Operating expenses

$          607,620

 

$          686,348

Operating income

$       1,096,703

 

$       1,695,375

Operating income as a percentage of revenue

28.3 %

 

32.1 %

Net income

$          946,483

 

$       1,460,575

Net income per diluted share

$                6.99

 

$              10.71

Shares used in per share calculation - diluted

135,395

 

136,339

 

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income

(in thousands, except per share data)

(unaudited) 

 
 

Three Months Ended

 

March 26,
2023

 

December 25,
2022

U.S. GAAP net income

$             814,008

 

$          1,468,507

Pre-tax non-GAAP items:

     

Amortization related to intangible assets acquired through certain business combinations - cost of goods sold

3,093

 

2,521

Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold

1,498

 

2,853

Restructuring charges, net - cost of goods sold

66,720

 

Product rationalization - cost of goods sold

26,842

 

Transformational costs - cost of goods sold

558

 

EDC related liability valuation increase  - research and development

2,697

 

5,136

Product rationalization - research and development

3,858

 

Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative

1,395

 

1,279

EDC related liability valuation increase - selling, general and administrative

1,798

 

3,424

Product rationalization - selling, general and administrative

2,891

 

Transformational costs - selling, general and administrative

2,692

 

Restructuring charges, net- operating expenses

40,408

 

Amortization of note discounts - other income (expense), net

718

 

712

Gain on EDC related asset - other income (expense), net

(5,443)

 

(10,871)

Net income tax benefit on non-GAAP items

(17,250)

 

(1,213)

Net income tax benefit associated with legal entity restructuring

 

(11,773)

Non-GAAP net income

$             946,483

 

$          1,460,575

Non-GAAP net income per diluted share

$                   6.99

 

$                 10.71

U.S. GAAP net income per diluted share

$                   6.01

 

$                 10.77

U.S. GAAP and non-GAAP number of shares used for per diluted share calculation

135,395

 

136,339

 

Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin,
Operating Expenses and Operating Income

(in thousands, except percentages)

(unaudited) 

 
 

Three Months Ended

 

March 26,
2023

 

December 25,
2022

U.S. GAAP gross margin

$       1,605,612

 

$       2,376,349

Pre-tax non-GAAP items:

     

Amortization related to intangible assets acquired through certain business combinations

3,093

 

2,521

EDC related liability valuation increase

1,498

 

2,853

Restructuring charges, net

66,720

 

Product rationalization

26,842

 

Transformational costs

558

 

Non-GAAP gross margin

$       1,704,323

 

$       2,381,723

U.S. GAAP gross margin as a percentage of revenue

41.5 %

 

45.0 %

Non-GAAP gross margin as a percentage of revenue

44.0 %

 

45.1 %

U.S. GAAP operating expenses

$          663,359

 

$          696,187

Pre-tax non-GAAP items:

     

Amortization related to intangible assets acquired through certain business combinations

(1,395)

 

(1,279)

EDC related liability valuation increase

(4,495)

 

(8,560)

Restructuring charges, net

(40,408)

 

Product rationalization

(6,749)

 

Transformational costs

(2,692)

 

Non-GAAP operating expenses

$          607,620

 

$          686,348

U.S. GAAP operating income

$          942,253

 

$       1,680,162

Non-GAAP operating income

$       1,096,703

 

$       1,695,375

U.S. GAAP operating income as percent of revenue

24.4 %

 

31.8 %

Non-GAAP operating income as a percent of revenue

28.3 %

 

32.1 %

 

Lam Research Corporation Contacts:
Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com

(PRNewsfoto/Lam Research)

 

SOURCE Lam Research Corporation

circle-arrow2circle-arrow2facebookgooglehandshake2health2linkedinmenupdfplant2searchtwitteryoutube